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Chapter 6 
Domesticating Poliovirus: Laboratory Monkeys and Vaccine 
Production 
Liza Piper
VACCINES ARE A TECHNOLOGY—a form of artifice—that reproduce the 
biological consequences of a first, authentic historical encounter between 
an individual and a virus, or a community and a virus by means of large-
scale vaccination campaigns.1 The artifice of vaccination depends entirely 
on the manipulation of nature. Vaccines are, after all, made from pathogens 
themselves. In anti-vaccination writings, authors focus on the unnatural 
additives to vaccines: the mercury (thimerosal) used as a preservative, the 
formaldehyde used to inactivate viruses and toxins, and the aluminum that 
is used as an adjuvant.2 Yet the use of the viruses themselves is just as 
remarkable. The process of polio vaccine production, for example, is a 
process of domestication as much as a process of fabrication. Within the 
landscapes of laboratories and across the topographies of animal bodies, 
wild polioviruses are taken and transformed into viruses under human 
control, which can then be deployed in large-scale vaccination programs. 
Sometimes, new viruses literally evolve out of the research process leading 
up to vaccine production, as with a neural-adapted, virulent strain of polio 
called the MV strain affecting only the central nervous system and no 
longer replicating in the intestines.3 In a 1974 interview with Saul Benison, 
Albert Sabin spoke with some regret about early work he had done using 
the MV strain, rather than “strains as they are found in nature, before they 
have been changed by many passages in the laboratory.” He referred to  
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Figure 1. Preparation of measles vaccine at the Tirana Institute of Hygiene and 
Epidemiology, Tirana, Albania, c.1969–1979. WHO / D. Henrioud (Photographer). 
strains including MV and others transformed in the laboratory as 
“artifacts” that were used out of ease, but did not permit conclusions about 
the “human disease or the original virus.”4 
Other-than-human nature is subjugated in many different ways in 
vaccine research and production. To grow viruses needed for vaccines 
outside of the human body historically required other bodies. The classic 
example of their deployment was Edward Jenner’s use of pus from cowpox 
blisters (albeit found on the hands of milkmaids, but contracted originally 
from cows) to inoculate against smallpox. Fertilized chicken eggs are used 
to grow vaccine strains of influenza, and historically limited supplies of 
fertilized chicken eggs impeded rapid vaccine production.5 
In the case of polio, monkeys were essential to biomedical research. 
Unlike most other laboratory animals (rabbits, guinea pigs, and mice), they 
were susceptible to polioviruses and were therefore essential for laboratory 
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Figure 2. Albert Sabin and a research monkey, c.1950s. Courtesy the Hauck Center for the 
Albert B. Sabin Archives, Henry R. Winkler Center for the History of the Health 
Professions, University of Cincinnati Libraries. 
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research on the disease. Indeed, they shaped the conditions of research into 
polio from 1908 until 1939. This included the need to transport monkeys 
during polio epidemics, as when seventy-five travelled by train with 
researchers to Los Angeles to investigate an outbreak there in 1934.6 By 
1939, a mouse-adapted strain (the Lansing strain) of polio had been isolated 
that permitted some experimental effort to be diverted from monkey to 
mouse bodies. 
Research undertaken between 1948 and 1955 at first promised to free 
monkeys entirely from their role in poliovirus research, but ended up 
greatly amplifying demand for their bodies. Researchers had attempted to 
grow poliovirus in vitro, “artificially” or “outside of the body,” with varying 
degrees of success since the 1910s.7 Then, in a 1949 article published in 
Science, John Enders, Thomas Weller, and Frederick Robbins described 
cultivating the Lansing strain in tissue cultures made from human embryos, 
including non-nervous tissues. This research demonstrated conclusively 
that polio was not exclusively a disease of the central nervous system.8 
More importantly, this work, by enabling virus reproduction in tissue 
cultures—a preparation made from living tissue to serve as an artificial 
medium for cell growth—liberated polioviruses from bodies, whether 
monkey, mouse, or human. This was a precursor to the mass reproduction 
of domesticated poliovirus strains needed for large-scale vaccine trials.  
The creation of ambiguous boundaries between nature and laboratory-
based artifice was central to the domestication of polioviruses, as seen with 
the evolution of laboratory-born poliovirus strains. The development of 
tissue cultures in turn moved much of the work from monkey bodies into 
test tubes and Povitsky bottles. But tissue cultures also needed to be kept 
and fed in conditions that closely approximated those experienced by living 
bodies. Techniques used by Jonas Salk and colleagues in his Pittsburgh 
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Figure 3. Dr. Leone Farrell and the “Toronto method” of poliovirus cultivation, 
Connaught Laboratories, 1953–1954. Sanofi Pasteur Canada (Connaught Campus) 
Archives, Toronto. 
laboratory drew on a method developed by George Otto Gey, which kept 
the tissue culture in motion, rocking it back and forth like a sleeping baby, 
exposing it alternately to air and food.9 The human embryonic tissues used 
by Enders, Weller, and Robbins were expensive and difficult to procure, 
however. By 1951, Salk and his colleagues had refined a technique to 
produce tissue cultures from monkey kidney cells for propagating large 
volumes of poliovirus. Salk and his colleagues used a nutrient solution 
called Medium 199, synthesized at the University of Toronto’s Connaught 
Laboratories. It contained over sixty ingredients ranging from vitamins to 
table salt, and included experimental amino acids, cell surface agents, 
nucleic acids, growth factors, and iron. The medium kept the tissue culture 
cells alive long enough to be infected by the virus, which was then allowed 
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to multiply until the cells were completely destroyed, leaving only the 
poliovirus suspended in a solution of Medium 199.10  
John R. Paul, medical historian and polio researcher, had reflected that 
with Enders, Wellers, and Robbins’ work, it was “wonderful to say, … that 
at long last monkeys, which had been so essential in the poliomyelitis 
laboratory, could be replaced by tissue cultures, for certain purposes at 
least. This marked an end, at least partially, of the monkey era.”11 Partially 
is the operative word here. Monkeys continued to be used in laboratories, 
even if research no longer depended on them. More important, the tissue 
cultures that replaced living animals had to be manufactured from monkey 
bodies. Really, then, this simply marked a shift from dealing with whole 
monkeys to monkey parts. Indeed, the scale of monkey harvesting 
increased dramatically in the context of vaccine production. Thus the 1949 
article by Enders, Weller, and Robbins can be seen as changing 
experimental conditions for virology in general by leading to “the large-
scale employment of nonhuman primates in the virus laboratory,” as well 
as paving the way for the manufacture of a polio vaccine.12  
In 1953, the National Foundation for Infantile Paralysis requested that 
the Connaught Medical Research Laboratories in Toronto assist in the 
preparation of virus fluids (infected tissue cultures) needed for the 
American trials of Salk’s vaccine. Scientists at Connaught had first engaged 
in poliomyelitis research in the late 1930s. Researchers were based either 
at the University of Toronto campus in downtown Toronto, Ontario, or 
out at what was initially called “the Farm”—a fifty-eight-acre property on 
the northern outskirts of the city. Both were essential landscapes of medical 
science in Canada, as Joanna Dean has also described in her chapter in this 
volume. The Farm was renamed the Dufferin Division after Princess Alice, 
Countess of Athlone, visited in 1943 and commented that the work was not 
what she expected of a “farm.”13  
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Figure 4. Dufferin Division of the Connaught Medical Research Laboratories (after the 
name change), 1940s. Sanofi Pasteur Canada (Connaught Campus) Archives, Toronto. 
At the Farm, horses were kept for the preparation of diphtheria 
antitoxin, which required injecting and bleeding the horses as well as 
facilities for refining and concentrating the antitoxin. Calves were kept for 
the manufacture of smallpox vaccine, and cows for the manufacture and 
testing of “beef” liver extracts, used in the regeneration of hemoglobin. 
Insulin was prepared from an alcoholic extract of minced pancreas glands 
of cattle or hogs. Cows were also used for research into bovine tuberculosis. 
The Farm housed colonies of guinea pigs, white mice, and rats. Its buildings 
featured animal operating theatres, laboratories, housing for staff and 
researchers, and some veterinary research facilities.14 Other manufacturing 
facilities and laboratories were located downtown in the University of 
Toronto’s Department of Hygiene, including cages for monkeys.15 By the 
1950s, when poliomyelitis vaccine development was at its peak, the 
monkeys too were moved out to the Farm. 
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In 1953, workers and scientists at Connaught prepared 5,521 litres of 
virus fluids that year, using over 7,000 monkeys in their production.16 In 
1954, the stables at the Dufferin Division were renovated to accommodate 
monthly shipments that had grown to as many as 1,500 monkeys. This 
enormous increase in demand for monkeys came not only from the 
Connaught Laboratories themselves, but also from laboratories across 
North America that were racing to develop an effective vaccine at the 
height of polio epidemics. Rhesus macaques were the animal of choice 
because their kidneys could be used for tissue cultures and because they 
were relatively easy to procure from dealers in India. Then, in 1955, 
concerned about these animals’ deaths and the poor conditions they 
encountered in transport, India imposed an export embargo on 
macaques.17 The importance of these monkeys to polio vaccine 
development led to political pressure from the United States and the 
United Kingdom. Both countries pushed India to reopen the trade on the 
condition that the monkeys be treated humanely and be used exclusively 
for medical research and vaccine production.18 In the context of societal 
anxiety over polio, Neel Ahuja has argued “that national officials [in the US] 
in charge of marshalling ‘research resources’ established the rhesus as the 
primary biomedical model for the human to be imported and preserved as 
a vital national resource.”19 
Even as rhesus macaques were becoming a biomedical model for 
humans, they were animals in their own right, needing care and treatment. 
Through the 1970s some continued to express concern that appropriate 
conservation measures were not being observed in the capture of macaques 
and other species earmarked for research purposes at the National 
Institutes of Health, and at private pharmaceutical research labs like the 
Connaught. There was also concern about the hazards posed by monkey 
bodies. In a 1971 review of the role of primates in virology, S.S. Kalter and 
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R.L. Heberling emphasized that “monkeys and apes must not be considered 
simply as ‘test tubes’… but as biological entities harboring a multitude of 
microbial and parasitic forms.”20 Certain microbes and parasites were 
encouraged by the trade and commerce in monkeys for experimentation. 
Tom Rivers, a leading American virologist at the Rockefeller Institute, 
described how   
[m]any investigators, in order to cut costs, would sell their monkeys 
to dealers if they survived given experiments and appeared hale and 
hearty. The dealers, in turn, would resell the monkeys to other 
laboratories. Under such conditions, an investigator could buy a 
monkey from a dealer and have no reason to suspect that the 
animal had ever seen a poliovirus when, in fact, it may have had all 
three types of poliovirus. And how was one to know at that time 
which type or combination of types it had had? No one knew about 
types. You can imagine how cockeyed some of the experimental 
results were, and they were cockeyed!21  
Kalter and Heberling emphasized that practices for the capture, 
shipping, and handling of non-human primates encouraged the spread of 
viruses between monkeys, and even across different monkey species. They 
noted that even when animals were trapped individually, they were then 
kept until shipment in gang cages, where viruses could readily be 
transmitted between animals. Likewise, cages that were not cleaned 
properly between shipments could harbour viruses and bacteria that could 
infect more recently trapped animals. Conditions in the exporting and 
importing countries were, these authors noted, “generally unhygienic,” 
with little attempt made to observe public health or sanitary practices. 
“Frequently,” they wrote, “the problem of organism interchange is 
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compounded in the importers’ holding areas as different species from all 
over the world are now brought together.”22  
Beyond the “cockeyed” research results Rivers described, the use of 
monkey kidneys for tissue culture, when combined with researchers’ 
inattention to the monkeys as disease carriers in their own right, had 
serious implications in the development of the polio vaccine. Monkey 
bodies were far from sterile test tubes, and over time, researchers became 
more aware of the dangers posed by indigenous monkey viruses. In 1932, 
William Brebner, a bacteriologist at the Rockefeller Institute working on 
poliomyelitis and a colleague of Albert Sabin, was infected and died after 
being bitten by a macaque. The virus he succumbed to was later identified 
as Herpes B (for Brebner), and the infectious agent became generally 
known as “virus B.”23 Given that this virus had been discovered in the 
process of poliomyelitis research, those involved in the development of 
vaccines using monkey kidney tissues recognized the possible presence of 
the virus in vaccines. They conducted significant testing, therefore, to 
ensure that the “virus was inactivated more quickly by the amount of 
formaldehyde used in preparing the vaccine than polioviruses and that no 
danger existed.”24 But virus B was by no means unique. As Kalter and 
Heberling described almost twenty years later, there were numerous 
potential viruses that existed in monkeys at the point of capture, or which 
could be transmitted under the conditions in which they were transported. 
Some of these viruses would go on to infect the tissue cultures, with visible 
effect: researchers had to dispose of waste tissue cultures and vaccines as 
part of the manufacturing process. One virus, later called Simian virus 40 
(SV40), did not cause sickness in infected macaques, but has since been 
linked to the development of mesothelioma, osteosarcoma, and 
ependymoma cancers in humans. Polio vaccines produced between 1955 
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and 1963 are thought to have been widely contaminated with SV40, due to 
the use of infected monkey kidney tissues.25  
Studying the process of vaccine discovery and production involves 
tracing the experiences of polioviruses into laboratories. In these 
landscapes of science, we see the domestication of polioviruses and the 
evolution of new poliovirus strains as a result of laboratory research 
conditions. We also see the role of monkeys in enabling the domestication 
of such viruses, and latterly, the liberation of domesticated polioviruses 
from the topographies of human and other-than-human bodies through 
the development of tissue cultures. This liberation led to an intensified 
dependence on monkeys as source material for substrate, rather than as 
living organisms. This narrowed focus on partial, rather than whole 
monkeys made possible the development of a vaccine that was fundamental 
to human control of wild polioviruses.
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